192 related articles for article (PubMed ID: 19491398)
81. EVI1 targets ΔNp63 and upregulates the cyclin dependent kinase inhibitor p21 independent of p53 to delay cell cycle progression and cell proliferation in colon cancer cells.
Nayak KB; Kuila N; Das Mohapatra A; Panda AK; Chakraborty S
Int J Biochem Cell Biol; 2013 Aug; 45(8):1568-76. PubMed ID: 23665236
[TBL] [Abstract][Full Text] [Related]
82. TIS7 regulation of the beta-catenin/Tcf-4 target gene osteopontin (OPN) is histone deacetylase-dependent.
Vietor I; Kurzbauer R; Brosch G; Huber LA
J Biol Chem; 2005 Dec; 280(48):39795-801. PubMed ID: 16204248
[TBL] [Abstract][Full Text] [Related]
83. The SANT domain of human MI-ER1 interacts with Sp1 to interfere with GC box recognition and repress transcription from its own promoter.
Ding Z; Gillespie LL; Mercer FC; Paterno GD
J Biol Chem; 2004 Jul; 279(27):28009-16. PubMed ID: 15117948
[TBL] [Abstract][Full Text] [Related]
84. Histone deacetylation of RB-responsive promoters: requisite for specific gene repression but dispensable for cell cycle inhibition.
Siddiqui H; Solomon DA; Gunawardena RW; Wang Y; Knudsen ES
Mol Cell Biol; 2003 Nov; 23(21):7719-31. PubMed ID: 14560017
[TBL] [Abstract][Full Text] [Related]
85. HDAC2 phosphorylation-dependent Klf5 deacetylation and RARα acetylation induced by RAR agonist switch the transcription regulatory programs of p21 in VSMCs.
Zheng B; Han M; Shu YN; Li YJ; Miao SB; Zhang XH; Shi HJ; Zhang T; Wen JK
Cell Res; 2011 Oct; 21(10):1487-508. PubMed ID: 21383775
[TBL] [Abstract][Full Text] [Related]
86. HDAC4 promotes growth of colon cancer cells via repression of p21.
Wilson AJ; Byun DS; Nasser S; Murray LB; Ayyanar K; Arango D; Figueroa M; Melnick A; Kao GD; Augenlicht LH; Mariadason JM
Mol Biol Cell; 2008 Oct; 19(10):4062-75. PubMed ID: 18632985
[TBL] [Abstract][Full Text] [Related]
87. A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest.
Claassen GF; Hann SR
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9498-503. PubMed ID: 10920185
[TBL] [Abstract][Full Text] [Related]
88. Transcriptional regulation of the cyclin-dependent kinase inhibitor, p21
Moussa RS; Kovacevic Z; Bae DH; Lane DJR; Richardson DR
Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):761-774. PubMed ID: 29032246
[TBL] [Abstract][Full Text] [Related]
89. Tumor suppressive BTB/POZ zinc-finger protein ZBTB28 inhibits oncogenic BCL6/ZBTB27 signaling to maintain p53 transcription in multiple carcinogenesis.
Xiang T; Tang J; Li L; Peng W; Du Z; Wang X; Li Q; Xu H; Xiong L; Xu C; Le X; Wei X; Yu F; Li S; Xiao Q; Luo B; Xiang X; Huang A; Lin Y; Ren G; Tao Q
Theranostics; 2019; 9(26):8182-8195. PubMed ID: 31754389
[TBL] [Abstract][Full Text] [Related]
90. Zinc-finger protein p52-ZER6 accelerates colorectal cancer cell proliferation and tumour progression through promoting p53 ubiquitination.
Huang C; Wu S; Li W; Herkilini A; Miyagishi M; Zhao H; Kasim V
EBioMedicine; 2019 Oct; 48():248-263. PubMed ID: 31521611
[TBL] [Abstract][Full Text] [Related]
91. TRIP-Br: a novel family of PHD zinc finger- and bromodomain-interacting proteins that regulate the transcriptional activity of E2F-1/DP-1.
Hsu SI; Yang CM; Sim KG; Hentschel DM; O'Leary E; Bonventre JV
EMBO J; 2001 May; 20(9):2273-85. PubMed ID: 11331592
[TBL] [Abstract][Full Text] [Related]
92. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
Wunderlich M; Berberich SJ
Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
[TBL] [Abstract][Full Text] [Related]
93. Histone deacetylase 3 represses p15(INK4b) and p21(WAF1/cip1) transcription by interacting with Sp1.
Huang W; Tan D; Wang X; Han S; Tan J; Zhao Y; Lu J; Huang B
Biochem Biophys Res Commun; 2006 Jan; 339(1):165-71. PubMed ID: 16298343
[TBL] [Abstract][Full Text] [Related]
94. Repression of myoblast proliferation and fibroblast growth factor receptor 1 promoter activity by KLF10 protein.
Parakati R; DiMario JX
J Biol Chem; 2013 May; 288(19):13876-84. PubMed ID: 23569208
[TBL] [Abstract][Full Text] [Related]
95. Human cytomegalovirus pUL29/28 and pUL38 repression of p53-regulated p21CIP1 and caspase 1 promoters during infection.
Savaryn JP; Reitsma JM; Bigley TM; Halligan BD; Qian Z; Yu D; Terhune SS
J Virol; 2013 Mar; 87(5):2463-74. PubMed ID: 23236067
[TBL] [Abstract][Full Text] [Related]
96. Disparate chromatin landscapes and kinetics of inactivation impact differential regulation of p53 target genes.
Gomes NP; Espinosa JM
Cell Cycle; 2010 Sep; 9(17):3428-37. PubMed ID: 20818159
[TBL] [Abstract][Full Text] [Related]
97. Involvement of the p53/p21 complex in p53-dependent gene expression.
Kim U; Kim KS; Park JK; Um HD
Biochem Biophys Res Commun; 2022 Sep; 621():151-156. PubMed ID: 35834924
[TBL] [Abstract][Full Text] [Related]
98. Nuclear hormone receptor corepressor promotes esophageal cancer cell invasion by transcriptional repression of interferon-γ-inducible protein 10 in a casein kinase 2-dependent manner.
Yoo JY; Choi HK; Choi KC; Park SY; Ota I; Yook JI; Lee YH; Kim K; Yoon HG
Mol Biol Cell; 2012 Aug; 23(15):2943-54. PubMed ID: 22675025
[TBL] [Abstract][Full Text] [Related]
99. The NCoR Co-repressor Interacts with the Kaiso Transcription Factor through a Mechanism Different from That of BCL6 Interaction.
Balagurov KI; Georgiev PG; Bonchuk AN
Dokl Biochem Biophys; 2022 Dec; 507(1):326-329. PubMed ID: 36786995
[TBL] [Abstract][Full Text] [Related]
100. A novel KRAB domain-containing zinc finger transcription factor ZNF431 directly represses Patched1 transcription.
He Z; Cai J; Lim JW; Kroll K; Ma L
J Biol Chem; 2011 Mar; 286(9):7279-89. PubMed ID: 21177534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
